[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE230389T1 - Angiogenese inhibitoren - Google Patents

Angiogenese inhibitoren

Info

Publication number
ATE230389T1
ATE230389T1 AT99102501T AT99102501T ATE230389T1 AT E230389 T1 ATE230389 T1 AT E230389T1 AT 99102501 T AT99102501 T AT 99102501T AT 99102501 T AT99102501 T AT 99102501T AT E230389 T1 ATE230389 T1 AT E230389T1
Authority
AT
Austria
Prior art keywords
angiogenesis inhibitors
angiogenesis
inhibitors
Prior art date
Application number
AT99102501T
Other languages
English (en)
Inventor
Chiho Fukiage
Mitsuyoshi Azuma
Jun Rui Inoue
Masayuki Nakamura
Yuka Yoshida
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE230389T1 publication Critical patent/ATE230389T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/48Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99102501T 1995-10-25 1996-10-23 Angiogenese inhibitoren ATE230389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27748595 1995-10-25
JP24804696 1996-09-19

Publications (1)

Publication Number Publication Date
ATE230389T1 true ATE230389T1 (de) 2003-01-15

Family

ID=26538555

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99102501T ATE230389T1 (de) 1995-10-25 1996-10-23 Angiogenese inhibitoren
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT96116994T ATE230275T1 (de) 1995-10-25 1996-10-23 Angiogense-inhibitor
AT99106760T ATE239698T1 (de) 1995-10-25 1996-10-23 Angiogenese hemmer

Country Status (13)

Country Link
US (2) US6057290A (de)
EP (2) EP0927716B1 (de)
AR (1) AR004694A1 (de)
AT (3) ATE230389T1 (de)
AU (1) AU716495B2 (de)
BR (1) BR9605267A (de)
CA (1) CA2188817C (de)
DE (3) DE69625575T2 (de)
ES (2) ES2190139T3 (de)
HU (1) HUP9602943A3 (de)
MX (1) MX9605156A (de)
NO (1) NO964514L (de)
PL (1) PL316669A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990028948A (ko) * 1995-07-13 1999-04-15 요시다 쇼지 피페라진 유도체 및 그의 용도
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
EP1022276B1 (de) * 1997-09-04 2003-05-28 Nippon Chemiphar Co., Ltd. Epoxybernsteinsäureamid-derivate
US6015787A (en) * 1997-11-04 2000-01-18 New England Medical Center Hospitals, Inc. Cell-permeable protein inhibitors of calpain
ATE400277T1 (de) 1998-03-05 2008-07-15 Senju Pharma Co Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
WO1999048522A1 (en) * 1998-03-20 1999-09-30 Senju Pharmaceutical Co., Ltd. Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
WO2000038717A2 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
AU3196300A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
KR20010001270A (ko) * 1999-06-03 2001-01-05 복성해 혈관신생을 억제하는 새로운 이소쿠마린 유도체
EP1221315A4 (de) 1999-10-13 2007-12-12 Senju Pharma Co Adhäsive ophthalmische zubereitungen zur perkutanen absporption
WO2001041757A1 (fr) * 1999-12-10 2001-06-14 Senju Pharmaceutical Co., Ltd. Composition pharmaceutique contenant de la cyclodextrine
AU2001292287A1 (en) * 2000-10-26 2002-05-06 Senju Pharmaceutical Co. Ltd. Drug composition comprising dipeptydyl aldehyde derivative
AU2002221066A1 (en) * 2000-12-12 2002-06-24 Senju Pharmaceutical Co. Ltd. Hydrazone derivatives and use thereof in medicines
CA2446719A1 (en) 2001-06-06 2002-12-12 Eli Lilly And Company Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
US7115607B2 (en) * 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
JPWO2003078415A1 (ja) * 2002-03-15 2005-07-14 千寿製薬株式会社 環状ヘミアセタール誘導体およびその用途
WO2003082837A1 (fr) 2002-03-29 2003-10-09 Senju Pharmaceutical Co., Ltd. Derive de l'hydroxymorpholinone et ses utilisations medicales
EP1354586A1 (de) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Verwendung von Hydroxypyridon Derivaten zur Wundheilung
AU2003248059A1 (en) * 2002-07-22 2004-02-09 Senju Pharmaceutical Co., Ltd. NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
GB0314262D0 (en) 2003-06-19 2003-07-23 Univ Nottingham Trent Novel compounds and methods of using the same
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US20120065793A1 (en) 2010-02-25 2012-03-15 Kaji Mitsuru Demand and supply control apparatus, demand and supply control method, and program
WO2012008159A1 (en) 2010-07-14 2012-01-19 Senju Pharmaceutical Co., Ltd. Solid dispersion of alfa-ketoamide derivatives
GB201218084D0 (en) * 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
GB201220474D0 (en) * 2012-11-14 2012-12-26 Sagetis Biotech Sl Polypeptides
US20210145930A1 (en) * 2018-05-07 2021-05-20 NeuroTheranostics, Inc. Multiple layer article with interactive reinforcements linear ribbon fiber reinforcement for composite forms
WO2022187491A1 (en) * 2021-03-03 2022-09-09 The Texas A& M University System Inhibitors of cysteine proteases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50137951A (de) 1974-04-27 1975-11-01
JPS5754157A (en) 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
JP2536754B2 (ja) * 1987-05-08 1996-09-18 日本ケミファ株式会社 ピペラジン誘導体
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
JP2701932B2 (ja) 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
DE69024400T2 (de) * 1989-04-28 1996-06-27 Takara Shuzo Co Dem menschlichen Calpastatin ähnliches Polypeptid
ZA921279B (en) 1991-02-22 1993-08-23 Du Pont Merck Pharma Substituted alpha-aminoaldehydes and derivatives
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JP2848232B2 (ja) 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
US5607831A (en) 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
US5658885A (en) 1993-04-27 1997-08-19 The Dupont Merck Pharmaceutical Company Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
WO1996010014A1 (en) * 1994-09-27 1996-04-04 Takeda Chemical Industries, Ltd. Aldehyde derivatives as upsteine protease inhibitors
US5614649A (en) 1994-11-14 1997-03-25 Cephalon, Inc. Multicatalytic protease inhibitors
EP0731107A1 (de) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
EP0824543A1 (de) 1995-05-10 1998-02-25 Chiroscience Limited Peptide, die metalloproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung
KR19990028948A (ko) * 1995-07-13 1999-04-15 요시다 쇼지 피페라진 유도체 및 그의 용도
AU714324B2 (en) 1995-11-28 2000-01-06 Cephalon, Inc. D-amino acid derived inhibitors of cysteine and serine proteases

Also Published As

Publication number Publication date
EP0927716A1 (de) 1999-07-07
ES2193615T3 (es) 2003-11-01
EP0771565B1 (de) 2003-01-02
DE69625622T2 (de) 2003-08-14
ES2190139T3 (es) 2003-07-16
AU716495B2 (en) 2000-02-24
US6551999B1 (en) 2003-04-22
EP0771565A2 (de) 1997-05-07
DE69625575D1 (de) 2003-02-06
DE69628050T2 (de) 2004-04-01
US6057290A (en) 2000-05-02
NO964514D0 (no) 1996-10-24
HUP9602943A2 (en) 1997-08-28
DE69628050D1 (de) 2003-06-12
ATE239698T1 (de) 2003-05-15
EP0771565A3 (de) 1998-11-04
ATE230275T1 (de) 2003-01-15
BR9605267A (pt) 1998-07-21
AR004694A1 (es) 1999-03-10
HUP9602943A3 (en) 1998-03-02
NO964514L (no) 1997-04-28
CA2188817A1 (en) 1997-04-26
CA2188817C (en) 2010-01-26
MX9605156A (es) 1998-05-31
AU7038496A (en) 1997-05-01
PL316669A1 (en) 1997-04-28
EP0927716B1 (de) 2003-05-07
DE69625622D1 (de) 2003-02-06
DE69625575T2 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
ATE230389T1 (de) Angiogenese inhibitoren
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
NO962381L (no) Spiss-beskytter-innretning
PT858464E (pt) Inibidores de trombina
DE59609887D1 (de) Substituierte cyanophenyluracile
NO980643D0 (no) Propylendopeptidase inhibitorer
DE59610332D1 (de) Substituierte aminouracile
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de) Substituierte benzylidencyanessigester
BR9610514A (pt) Inibidores cicloantihelmínticos
DE59607958D1 (de) Substituierte phenyluracile
FI1943U1 (fi) Bomsystem till skogmaskin
KR970703937A (ko) 금속단백질 분해효소 억제제(Metallproteinase inhibitors)
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β
NO950285D0 (no) Teletorgteknikk
BR9503278A (pt) Dispositivos absorventes bucais
FI2196U1 (fi) Snoestyrningsblad till snoeslunga
FI2002U1 (fi) Haollare till spoestaell
FI2187U1 (fi) Hoerndetalj till plaottlaoda
FI1863U1 (fi) Vaeggkonstruktion till timmerhus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties